NEW YORK (GenomeWeb) – Sophia Genetics announced today that it has closed a $15 million Series C financing round led by Belgian billionaire Marc Coucke, the founder of Omega Pharma.

The Swiss genetics company will use the funds to add to its line of genomic tests and continue expanding its market, it said in a statement. Sophia added that it has seen a 400 percent growth rate in 2015, led by its analytics platform, Sophia Data Driven Medicine.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.